Selective delivery of IFN‐γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis-Reference-Cited by-同舟云学术

Selective delivery of IFN‐γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis

Published:2014-12-02 Issue:3 Volume:29 Page:1029-1042
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Poosti Fariba¹,Bansal Ruchi²,Yazdani Saleh²,Prakash Jai²,Post Eduard³,Klok Pieter¹,Born Jacob⁴,Borst Martin H.⁴,Goor Harry¹,Poelstra Klaas³,Hillebrands Jan‐Luuk¹

Affiliation:

1. Department of Pathology and Medical BiologyDivision of PathologyUniversity of GroningenGroningenThe Netherlands

2. MIRA InstituteUniversity of TwenteEnschedeThe Netherlands

3. Department of Pharmacokinetics, Toxicology and TargetingUniversity of GroningenGroningenThe Netherlands

4. Department of Internal MedicineDivision of NephrologyUniversity Medical Center GroningenUniversity of GroningenGroningenThe Netherlands

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.14-258459

Reference66 articles.

1. Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2. Therapy for Fibrotic Diseases: Nearing the Starting Line

3. Cellular and molecular mechanisms in kidney fibrosis

4. Molecular basis of renal fibrosis

5. Fibroblasts and myofibroblasts in renal fibrosis

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways;International Immunopharmacology;2024-08

2. Investigation of multinucleation and apoptosis of macrophages of BCG-infected mice and their production of cathepsins and matrix metalloproteinases;Сибирский научный медицинский журнал;2024-04-27

3. A quantitative review of nanotechnology‐based therapeutics for kidney diseases;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Protein and peptide-based renal targeted drug delivery systems;Journal of Controlled Release;2024-02

5. Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice;Oncotarget;2024-01-24